Author: BusinessWire

Target Selector™ EGFR assays offer ultra-high sensitivity and require less tumor sample than most commercial assays
SAN DIEGO–(BUSINESS WIRE)–Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, wil…

reSET-O® is the first and only FDA-authorized Prescription Digital Therapeutic (PDT) for patients with opioid use disorder (OUD).

Health economic analysis showed reSET-O to be more effective and less costly compared to treatment-as-usual alone ove…

Innovative Nasal High-Flow Therapy Provides Respiratory Support for Patients with COVID-19 and Other Respiratory Conditions
IRVINE, Calif.–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) today announced the U.S. introduction of softFlow®, innovative pulmonary…

$164.5M in Rubraca® (rucaparib) global net product revenues for 2020, up 15% over 2019; $43.3M in Rubraca global net product revenues for Q4 2020, up 10% over Q4 2019

Phase 1/2 LuMIERE study of FAP-2286, a targeted radiotherapy, planned to begin 1H…

Company adds two directors with financial, pharmaceutical, and consumable business expertise
BOSTON–(BUSINESS WIRE)–908 Devices Inc. (NASDAQ: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular ana…

New Appointments Bring Extensive Ocular Drug Delivery, Strategy and Scientific Expertise to Advance the Sustained Release of Biologics and Small Molecules into the Eye to Treat Sight-Threatening Eye Diseases
BELFAST, Northern Ireland–(BUSINESS WIRE)…

CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M. Culley, Ch…

ALLENDALE, Mich.–(BUSINESS WIRE)–#relyonabond–Dr. Phil Doren, Chief Executive Officer and Vice President, is pleased to announced today that Zoran Antonijevic is the Vice President, Statistical Consulting at Abond CRO Inc. “With this single appointm…

PHILADELPHIA–(BUSINESS WIRE)–Aro Biotherapeutics, a biotechnology company pioneering the development of tissue-targeted genetic medicines, today announced that Adam Dinerman, Ph.D. and John Liu, Ph.D. have joined the company as Executive Director, He…

CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exicure, Inc. (Nasdaq: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, today announced that CEO David Giljohann will present at the 2021 H….